Palisade Bio (PALI) Enterprise Value Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -113.59% |
| Dec 31, 2025 | -120.30% |
| Sep 30, 2025 | 27.97% |
| Jun 30, 2025 | -2.84% |
| Mar 31, 2025 | -2.86% |
| Dec 31, 2024 | 2.38% |
| Sep 30, 2024 | 17.08% |
| Jun 30, 2024 | 3.55% |
| Mar 31, 2024 | -163.69% |
| Dec 31, 2023 | -159.31% |
| Sep 30, 2023 | -173.19% |
| Jun 30, 2023 | -121.03% |
| Mar 31, 2023 | -9.85% |
| Dec 31, 2022 | -34.28% |
| Sep 30, 2022 | -24.20% |
| Jun 30, 2022 | -29.72% |
| Mar 31, 2022 | -18.38% |
| Dec 31, 2021 | -21.95% |
| Sep 30, 2021 | -34.96% |
| Jun 30, 2021 | -21.28% |
| Mar 31, 2021 | 60.16% |
| Dec 31, 2020 | 60.62% |
| Sep 30, 2020 | 62.34% |
| Jun 30, 2020 | 48.99% |
| Mar 31, 2020 | 15.60% |
| Dec 31, 2019 | 36.73% |
| Sep 30, 2019 | -8.75% |
| Jun 30, 2019 | 41.04% |
| Mar 31, 2019 | 19.30% |
| Dec 31, 2018 | 22.08% |
| Sep 30, 2018 | 31.88% |
| Jun 30, 2018 | 33.09% |
| Mar 31, 2018 | 30.23% |
| Dec 31, 2017 | 24.87% |
| Sep 30, 2017 | 19.49% |
| Jun 30, 2017 | 27.66% |
| Mar 31, 2017 | 20.62% |
| Dec 31, 2016 | -6.23% |
| Sep 30, 2016 | 29.79% |
| Jun 30, 2016 | 0.11% |
| Mar 31, 2016 | 15.56% |
| Dec 31, 2015 | -18.01% |
| Sep 30, 2015 | -22.50% |
| Jun 30, 2015 | -110.48% |
| Mar 31, 2015 | -77.21% |
| Dec 31, 2014 | -127.04% |
| Sep 30, 2014 | -85.90% |
| Jun 30, 2014 | -70.11% |
| Mar 31, 2014 | -57.42% |
| Dec 31, 2013 | -22.07% |
| Sep 30, 2013 | -12.28% |
| Jun 30, 2013 | 7.32% |